CASI insider filings
CASI Pharmaceuticals, Inc. — 25 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-09-09. Screen CASI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CASI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — CASI Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-09-09 | 4 | Zukiwski Alexander A — EVP and Chief Medical Officer | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2022-09-08 | 4 | Huang James — Director | Purchase (P): 19,162 @ $3.89 · Purchase (P): 3,111 @ $4.00 · Purchase (P): 33,300 @ $4.28 | EDGAR |
| 2022-09-02 | 4 | Huang James — Director | Purchase (P): 24,975 @ $3.75 · Purchase (P): 11,821 @ $3.72 · Purchase (P): 400 @ $3.74 | EDGAR |
| 2022-08-26 | 4 | Huang James — Director | Purchase (P): 5,000 @ $3.75 · Purchase (P): 39,527 @ $3.75 | EDGAR |
| 2022-08-23 | 4 | Huang James — Director | Purchase (P): 171,116 @ $3.27 · Purchase (P): 23,105 @ $3.46 · Purchase (P): 40,000 @ $3.50 | EDGAR |
| 2022-06-17 | 4 | He Wei-Wu — Chairman and CEO, Director, 10% owner | Purchase (P): 36,058 @ $2.97 · Purchase (P): 2,096 @ $3.06 · Purchase (P): 50,000 @ $3.18 | EDGAR |
| 2022-05-26 | 4 | Wu Yue Alexander — Director | Grant/award (A): 388,387 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | Salisbury Franklin Cary jr — Director | Grant/award (A): 388,387 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | Huang James — Director | Grant/award (A): 397,419 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | Zhou Quan — Director | Grant/award (A): 380,645 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | SHROTRIYA RAJESH C MD — Director | Grant/award (A): 345,806 (derivative) @ $0 | EDGAR |
| 2021-12-06 | 4 | Zukiwski Alexander A — Chief Medical Officer | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2021-11-19 | 4 | He Wei-Wu — Chairman and CEO, Director | Purchase (P): 200,000 @ $0.99 · Purchase (P): 200,000 @ $0.98 | EDGAR |
| 2021-08-20 | 4 | He Wei-Wu — Chairman and CEO, Director | Purchase (P): 300,000 @ $1.29 · Purchase (P): 180,000 @ $1.26 | EDGAR |
| 2021-07-26 | 4 | Zhang Larry — President | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Wu Yue Alexander — Director | Grant/award (A): 110,459 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Salisbury Franklin Cary jr — Director | Grant/award (A): 110,459 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Huang James — Director | Grant/award (A): 113,028 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | He Wei-Wu — Chairman and CEO, Director, 10% owner | Grant/award (A): 4,000,000 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Zhou Quan — Director | Grant/award (A): 108,257 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | SHROTRIYA RAJESH C MD — Director | Grant/award (A): 98.35 (derivative) @ $0 | EDGAR |
| 2021-03-30 | 4 | He Wei-Wu — Chairman and CEO, Director | Purchase (P): 3,000,000 @ $2.05 | EDGAR |
| 2020-12-23 | 4 | He Wei-Wu — Chairman and CEO, Director | Gift (G): 380,000 @ $0 | EDGAR |
| 2020-12-18 | 4 | Xu Weihao — Chief Financial Officer | Purchase (P): 2,000 @ $2.44 · Purchase (P): 1,721 @ $2.64 · Purchase (P): 2,279 @ $2.63 · Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2020-11-24 | 4 | He Wei-Wu — Chairman and CEO, Director | Purchase (P): 127,471 @ $2.12 · Purchase (P): 100,000 @ $2.18 | EDGAR |
Recent 8-K events — CASI Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-03-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-26 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-25 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-05-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CASI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs